• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶抑制对胎儿肾脏的影响:肾血流量减少。

Effect of ACE inhibition on the fetal kidney: decreased renal blood flow.

作者信息

Martin R A, Jones K L, Mendoza A, Barr M, Benirschke K

机构信息

Department of Pediatrics, University of California Medical Center, San Diego 92103.

出版信息

Teratology. 1992 Oct;46(4):317-21. doi: 10.1002/tera.1420460402.

DOI:10.1002/tera.1420460402
PMID:1412062
Abstract

The kidneys of nine fetuses whose mothers were chronically hypertensive were examined microscopically. Three of these mothers used antihypertensive agents throughout pregnancy including one who used an angiotensin-converting enzyme (ACE) inhibitor. The tubular defects found in these kidneys were compared to the kidneys of 20 normal controls, 13 fetuses with various multiple malformation syndromes and six cases of the twin to twin transfusion syndrome. Evidence from these cases as well as the literature suggest that the primary mechanism by which ACE inhibitors affect development of the fetal kidney is through decreased renal blood flow.

摘要

对9名母亲患有慢性高血压的胎儿的肾脏进行了显微镜检查。这些母亲中有3人在整个孕期都使用了抗高血压药物,其中1人使用了血管紧张素转换酶(ACE)抑制剂。将这些肾脏中发现的肾小管缺陷与20名正常对照胎儿、13名患有各种多发畸形综合征的胎儿以及6例双胎输血综合征病例的肾脏进行了比较。这些病例以及文献中的证据表明,ACE抑制剂影响胎儿肾脏发育的主要机制是肾血流量减少。

相似文献

1
Effect of ACE inhibition on the fetal kidney: decreased renal blood flow.血管紧张素转换酶抑制对胎儿肾脏的影响:肾血流量减少。
Teratology. 1992 Oct;46(4):317-21. doi: 10.1002/tera.1420460402.
2
ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection.血管紧张素转换酶抑制剂胎儿病与颅骨发育不全:肾-颅骨关联
Teratology. 1991 Nov;44(5):485-95. doi: 10.1002/tera.1420440503.
3
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.与接触血管紧张素转换酶抑制剂和血管紧张素受体拮抗剂相关的胎儿病
Early Hum Dev. 2006 Jan;82(1):23-8. doi: 10.1016/j.earlhumdev.2005.11.001. Epub 2006 Jan 19.
4
Angiotensin converting enzyme inhibitor fetopathy.血管紧张素转换酶抑制剂致胎儿病变
Indian Pediatr. 1999 Jan;36(1):79-82.
5
Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.1987 - 1995年美国、加拿大和以色列妊娠头三个月使用血管紧张素转换酶抑制剂的上市后监测
MMWR Morb Mortal Wkly Rep. 1997 Mar 21;46(11):240-2.
6
[Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].[妊娠期高血压。由于其潜在的胎儿毒性,ACE抑制剂和血管紧张素II受体拮抗剂禁用]
Med Monatsschr Pharm. 2011 Oct;34(10):358-62.
7
Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant.一名早产儿接受血管紧张素II受体拮抗剂的孕期治疗与短暂性肾衰竭
Am J Perinatol. 2006 Jul;23(5):313-7. doi: 10.1055/s-2006-947162. Epub 2006 Jun 23.
8
From the Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.来自疾病控制与预防中心。1987 - 1995年美国、加拿大和以色列孕期头三个月使用血管紧张素转换酶抑制剂的上市后监测。
JAMA. 1997 Apr 16;277(15):1193-4.
9
Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors.
Teratology. 1991 Jun;43(6):543-6. doi: 10.1002/tera.1420430602.
10
ACE inhibitors and birth defects.
Prescrire Int. 2006 Dec;15(86):223.

引用本文的文献

1
Safety and Risks of Antihypertensive Medications During Breastfeeding: A Review of Current Guidelines.母乳喂养期间抗高血压药物的安全性与风险:现行指南综述
J Clin Med. 2025 May 26;14(11):3722. doi: 10.3390/jcm14113722.
2
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors.预防癌症幸存者蒽环类药物所致心脏毒性的策略。
Cardiooncology. 2019 Dec 2;5:18. doi: 10.1186/s40959-019-0054-5. eCollection 2019.
3
Reversible Fetal Renal Impairment following Angiotensin Receptor Blocking Treatment during Third Trimester of Pregnancy: Case Report and Review of the Literature.
妊娠晚期血管紧张素受体阻滞剂治疗后可逆性胎儿肾损伤:病例报告及文献复习
Case Rep Obstet Gynecol. 2016;2016:2382031. doi: 10.1155/2016/2382031. Epub 2016 Sep 8.
4
An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.血管紧张素转换酶抑制剂对胎儿-胎盘循环及围产期发育影响的综述。
Mol Cell Biochem. 1997 Nov;176(1-2):61-71.
5
Renal tubular dysgenesis with calvarial hypoplasia: report of two additional cases and review.伴有颅骨发育不全的肾小管发育不全:另外两例报告及文献复习
J Med Genet. 1997 Oct;34(10):846-8. doi: 10.1136/jmg.34.10.846.
6
The management of diabetes in pregnancy.妊娠期糖尿病的管理
Postgrad Med J. 1996 Sep;72(851):525-31. doi: 10.1136/pgmj.72.851.525.
7
The management of pregnancy in hypertensive patients.高血压患者的妊娠管理。
Postgrad Med J. 1994 Nov;70(829):790-7. doi: 10.1136/pgmj.70.829.790.
8
Deleterious effects of inhibition of the renin-angiotensin system in neonatal rats.抑制新生大鼠肾素-血管紧张素系统的有害影响。
Pediatr Nephrol. 1995 Jun;9(3):303-8. doi: 10.1007/BF02254192.